Handbook of Neurotoxicity

The Handbook of Neurotoxicity is a reference source for identifying, characterizing, instructing on use, and describing outcomes of neurotoxin treatments – to understand mechanisms associated with toxin use; to project outcomes of neurotoxin treatments; to gauge neurotoxins as predictors of events l...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Kostrzewa, Richard M. (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: New York, NY : Springer New York : Imprint: Springer, 2014.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
Πίνακας περιεχομένων:
  • Glutamate as a Neurotoxin,- Methamphetamine and MDMA neurotoxicity: Biochemical and molecular mechanisms
  • Microglia: Neuroprotective and Neurodestructive Properties
  • Neuroprotection in Demyelinating Diseases: the therapeutic potential of the neurotrophins
  • Neurotrophic Factors and Ethanol Neurotoxicity
  • Neurotrophic factors and NeuroAIDS: a lesson from brain-derived neurotrophic factor
  • Neurotrophins and p75NTR in axonal regeneration and myelination
  • Neurotrophins and pain
  • Neurotrophin signalling in Cancer
  • NGF and immune regulation
  • NGF/P75 in cell cycle and tetraploidy
  • P75 in neuronal death
  • p75NTR processing and signaling: functional role
  • p75NTR-A molecule with multiple functions in amyloid-beta metabolism and neurotoxicity
  • RCSN Cell System for Identifying Dopaminergic Neurotoxicity
  • Seizures tip the balance of neurotrophin signaling towards neuronal death
  • Survey of Selective Neurotoxins
  • Synthesis, trafficking and release of bdnf
  • The Nature of DSP-4-Induced Neurotoxicity
  • Trafficking of neurotrophins and their receptors and pathological significance
  • TRPV1 activators ("vanilloids") as neurotoxins
  • Experimental Approach to Alzheimer Disease
  • Iron-induced dopaminergic cell death in vivo as a model of Parkinson´s disease
  • Molecular, cellular and behavioural effects produced by perinatal asphyxia: protection by poly (ADP-ribose) polymerase 1 (PARP-1) inhibition
  • MPTP: advances from an evergreen neurotoxin
  • Multifunctional compounds for Parkinsons disease and Alzheimers disease
  • Nanomedicines for Nervous System Diseases
  • Neurodegenerative aspects of multiple system atrophy
  • Neurotoxic profiles of designer-drugs
  • Pathophysiology of obsessive-compulsive disorder: Insights from normal function and neurotoxic effects of drugs, infection and brain injury
  • Physical Exercise as Intervention in Parkinsonism
  • Protective agents in Parkinson´s disease: caffeine and adenosine A2A receptor antagonists
  • Stem Cell Therapies for Age Associated Neurodegeneration
  • AIDS
  • Excitotoxicity and axon degeneration
  • Glutamate Neurotoxicity related to Energy Failure
  • Neuroprotection by Kynurenine Metabolites
  • Pain
  • Quinolinate and related excitotoxins: mechanisms of neurotoxicity and disease relevance
  • Role of Ionotropic Glutamate Receptors in Neurodegenerative and Other Disorders
  • Tardive Dyskinesia: Outcome of antipsychotic treatment and brain damage?
  • The Concept of Excitotoxicity via Glu-R
  • The pathogenesis of Alzheimers disease
  • 5,6- and 5,7-Dihydroxytryptamines as Serotoninergic Neurotoxins
  • Neurotoxicity of Methamphetamine
  • Neurotoxic Effects, Mechanisms and Outcome of 192-IgG Saporin
  • Neurotrophic therapy for ALS/ MND
  • Cancer-mediated neurotoxicity
  • Neurotoxicity in psychostimulant and opiate addiction
  • Excitotoxicity in HIV associated neurocognitive disorders
  • Necroptosis, a potential therapeutic target for neurological disorders
  • Epilepsy
  • Excitotoxicity and Amyotrophic Lateral Sclerosis
  • Excitotoxicity in the Pathogenesis of Autism
  • Glutamate Neurotoxicity, Transport and Alternate Splicing of Transporters
  • Glutamatergic receptors in Parkinson`s disease
  • Ionotropic Receptors in the Central Nervous System and Neurodegenerative Disease
  • Lead & excitotoxicity
  • Molecular Mechanism and Effects of Clostridial Neurotoxins
  • MS & excitotoxicity
  • Neuroprotectants Targeting NMDA Receptor Signaling
  • Neurotoxicity and ALS: Insights into Pathogenesis
  • Schizophrenia
  • Neurotoxic Vulnerability Underlying Schizophrenia Spectrum Disorders
  • Glutamate in the Pathogenesis of Gliomas
  • Neurotoxicity and Neuroprotection in Spinal Cord Injury
  • Drug Abuse Neurotoxicity: Alcohol and Nicotine as Developmental Stressors
  • Botulinum neurotoxins as therapeutics
  • MPTP Neurotoxicity: Actions, Mechanisms and Animal Modeling of Parkinsons disease
  • Endogenous Kynurenic acid and Neurotoxicity
  • The potential therapeutic effects of statins in Alzheimer's disease
  • Drug Treatments for Alzheimer´s Disease: Hopes and Challenges
  • Glutamate and Neurodegeneration in the Retina
  • Stroke
  • Brain trauma Neuroprotection
  • Neuroprotective Strategies in Amyotrophic Lateral Sclerosis: Modulation of Neurotransmittory and Neurotrophic Input to Motor Neurons
  • The role of Neurotoxicity in Depression
  • Advances in stem cell research for Parkinson disease
  • Neurotoxicity in Huntington Disease
  • Fusion Models and ´Fusioning`in Parkinsonism: Protection and Restoration by Exercise
  • Neurotoxicity: a complex multistage process involving different mechanisms.